A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care Therapy

Clinical trial NCT00270387 · COMPLETED

Trial details

NCT number: NCT00270387
Sponsor: Scios, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiomyopathies Heart Failure, Congestive Dyspnea, Paroxysma

Start date: 2001-01-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.